Prescription Information Modernization Act of 2025
- senate
- house
- president
Last progress June 11, 2025 (5 months ago)
Introduced on June 11, 2025 by Markwayne Mullin
Sponsors (2)
House Votes
Senate Votes
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Presidential Signature
AI Summary
This bill lets drug makers share FDA‑approved prescribing information online instead of in paper form. Doctors and pharmacists must still be able to choose paper or request it any time, and the company has to send it quickly and for free . The health department must write rules within one year to put this in place and explain how health care professionals can get paper copies. Those rules should try to avoid extra costs for prescribers and pharmacies . A public workshop must be held within two years to keep improving the format, access, and ease of use of this information . The change applies to drugs entering the market on the earlier of two years after the law is enacted or when the final rules take effect .
Key points:
- Who is affected: Drug manufacturers; doctors and other prescribers; pharmacists; patients indirectly through how information is shared .
- What changes: Prescribing information can be provided digitally only, with a guaranteed no‑cost paper option on request; federal rules will guide how to get paper copies and aim to limit extra costs for clinics and pharmacies .
- When: Rules due within 1 year; public workshop within 2 years; policy starts for new market entries on the earlier of 2 years after enactment or when the rules take effect .